Memon et al., 2013 - Google Patents
Prevalence of type 2 diabetes mellitus in hepatitis C virus infected population: a Southeast Asian studyMemon et al., 2013
View PDF- Document ID
- 3695542369258304772
- Author
- Memon M
- Arain Z
- Naz F
- Zaki M
- Kumar S
- Burney A
- Publication year
- Publication venue
- Journal of diabetes research
External Links
Snippet
Purpose. The study was aimed to investigate the frequency of diabetes mellitus type 2 in patients infected with chronic hepatitis C virus and its association with cirrhosis. Patients and Methods. This prospective case series was conducted at Section of Gastroenterology and …
- 241000711549 Hepacivirus C 0 title abstract description 63
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay for hepatitis non-A, non-B hepatitis
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Memon et al. | Prevalence of type 2 diabetes mellitus in hepatitis C virus infected population: a Southeast Asian study | |
Bartlett et al. | The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: impact of direct acting antivirals | |
Gomez et al. | Sex differences in COVID-19 hospitalization and mortality | |
Stepanova et al. | Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity | |
Rao et al. | Distribution and clinical correlates of viral and host genotypes in C hinese patients with chronic hepatitis C virus infection | |
Armstrong et al. | The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | |
Qua et al. | Liver cirrhosis in Malaysia: peculiar epidemiology in a multiracial Asian country | |
Papatheodoridis et al. | Barriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic review | |
Spradling et al. | Incidence of diabetes mellitus in a population‐based cohort of persons with chronic hepatitis B virus infection | |
Lee et al. | Polymorphisms near the IFNL3 gene associated with HCV RNA spontaneous clearance and hepatocellular carcinoma risk | |
Kong et al. | Factors associated with spontaneous clearance of hepatitis C virus in Chinese population | |
Darvishian et al. | Loss to follow‐up: a significant barrier in the treatment cascade with direct‐acting therapies | |
Ali et al. | Association of Hepatitis C Virus Infection with Type II Diabetes in Ethiopia: A Hospital‐Based Case‐Control Study | |
Zider et al. | Prognostic significance of infections in critically ill adult patients with acute liver injury: a retrospective cohort study | |
Hwang et al. | Impact of HCV infection on diabetes patients for the risk of end-stage renal failure | |
Min Thaung et al. | Treatment outcomes and costs of a simplified antiviral treatment strategy for hepatitis C among monoinfected and HIV and/or hepatitis B virus‐co‐infected patients in Myanmar | |
Baatarkhuu et al. | Prevalence and genotype distribution of hepatitis C virus among apparently healthy individuals in Mongolia: a population‐based nationwide study | |
Petta et al. | TM 6 SF 2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C | |
Satsangi et al. | Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C | |
Prince et al. | Screening emergency admissions at risk of chronic hepatitis C (SEARCH) to diagnose or ‘re‐diagnose’infections is effective in Australia | |
Gencay et al. | Detection of in vivo hepatitis B virus surface antigen mutations—A comparison of four routine screening assays | |
Kierepa et al. | Impact of chronic HCV treatment on quality of life of patients with metabolic disorders in context of immunological disturbances | |
Ko et al. | Epidemiology of viral hepatitis C: Road to elimination in Japan | |
Kallman et al. | Vietnamese community screening for hepatitis B virus and hepatitis C virus | |
Zanini et al. | Addicts with chronic hepatitis C: Difficult to reach, manage or treat? |